CCM
NXTM

Cadian Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Cadian Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-483,450
Closed -$7.25M – 67
2016
Q1 		$7.25M Buy
+483,450
New +$8.1M 0.49% 35

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Cadian Capital Management's NXTM Position: Q2 2016 in Review

Cadian Capital Management sold out of NxStage Medical Inc. (NXTM) in Q2 2016, closing a stake of 483,450 shares — an estimated $7.25M sold.

Cadian Capital Management first reported a position in NXTM in Q1 2016 and held it in 1 quarter. The position peaked at $7.25M in Q1 2016. 147 funds tracked by Wall St. Rank hold NXTM as of Q2 2016.

  • Cadian Capital Management reported no remaining NxStage Medical Inc. position as of Q2 2016 after selling out during the quarter.
  • Cadian Capital Management sold 483,450 NxStage Medical Inc. shares in Q2 2016, an estimated $7.25M.
  • Cadian Capital Management first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 1 quarter.
  • Cadian Capital Management's NxStage Medical Inc. position peaked at $7.25M in Q1 2016.
  • 147 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2016.

Based on Cadian Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.